What is the problem you're trying to solve?
The rapid acceleration of genetic testing has created a deluge of never-seen-before genetic variations, known as Variants of Unknown Significance (VUS). VUS cause 60% of genetic tests to be inconclusive, which leads to mis-or-non diagnosis for patients.
How is what you're doing different than other attempts to solve this problem?
We’ve built a first-of-its-kind knowledgebase of gene function information that enables clinicians to understand the biological consequences of genetic variants, including VUS, before they’re ever seen in a patient. With our proprietary, high-throughput genetic synthesis and analysis system, we generate biologically, computationally, and clinically validated data, then translate that data into clinician-friendly information that can be applied to genetic testing analysis. Ranomics is dedicated to helping hospitals and cancer centers remove uncertainty from genetic testing results.
Why are you passionate about what you're working on?
I believe that understanding human genomics, in particularly for the application of human diseases, will be important in the era of personalized and preventative medicine. My vision is to understand the consequences of all mutations in all human disease genes, and apply this information to improve the areas of genetic testing and therapeutics.
What achievement are you most proud of?
Co-founding Ranomics at the age of 18.